Law360 (January 1, 2019, 12:03 PM EST) -- Merck's appeal to the U.S. Supreme Court of a Third Circuit decision that revived multidistrict litigation over its alleged failure to warn of a risk of femoral fractures from its osteoporosis drug Fosamax will be one of the most highly watched cases by product liability attorneys in 2019.
Attorneys will also be closely following the enormous MDL over the opioid crisis — with the first bellwether trials set to begin in early March — along with bellwether trials scheduled in the MDL over claims that Monsanto's weedkiller Roundup causes cancer and another Supreme Court case involving maritime law and asbestos claims.
Merck Sharp &...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!